This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Canadian Psoriasis Network Launches On World Psoriasis Day

National organization will advocate for the one million Canadians who live with psoriasis

ST. JOHN'S, Oct. 28, 2013 /CNW/ - The Canadian Psoriasis Network (CPN), a Canadian-based patient network for those living with psoriasis and psoriatic arthritis will launch on World Psoriasis Day on October 29 th.

Psoriasis is a chronic inflammatory, genetic disease of the immune system that appears most visibly on the skin, causing it to crack, itch and bleed. It also greatly elevates the risk of cardio vascular disease, diabetes, depression and obesity. It is the most common autoimmune disease in the country, affecting as many as 1 million Canadians. Up to 30 percent of people with psoriasis develop psoriatic arthritis, which causes pain and swelling of the joints. If left untreated, psoriatic arthritis can cause irreversible joint damage.

The Canadian Psoriasis Network has become a voice and source of information for psoriasis sufferers. Andrew Gosse, who has lived with psoriasis for 25 years, founded the organization.

"I created the Canadian Psoriasis Network to speak up for people living with this disease," says Andrew Gosse, Founder, Canadian Psoriasis Network. "As someone who has lived with and suffered from psoriasis for many years, I know that it's crucial to be informed about the disease. There are successful treatment options available and there are brighter days ahead. I don't want anyone living with this disease to feel as hopeless as I did for many years."

The CPN has developed a Bill of Rights and Responsibilities to help psoriasis patients get the care they need by encouraging doctors to take psoriatic disease more seriously and to keep informed about treatment options. The bill emphasizes the rights for psoriatic patients to receive medical care from a healthcare provider who understands that psoriasis and psoriatic arthritis are serious autoimmune diseases which are often undertreated or ignored.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
TSLA $150.59 -7.40%
YHOO $26.72 -4.50%
AAPL $94.22 0.21%
FB $100.02 -3.90%
GOOG $673.68 -1.40%


Chart of I:DJI
DOW 15,885.08 -319.89 -1.97%
S&P 500 1,842.45 -37.60 -2.00%
NASDAQ 4,259.1850 -103.9590 -2.38%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs